Sirio Pharma (SHE:300791) — Stock Price
Sirio Pharma (SHE:300791) is currently trading at CN¥17.31 CNY, up 2.12% today. Over the past 52 weeks, shares have ranged between CN¥15.63 and CN¥26.20. This page tracks Sirio Pharma's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Sirio Pharma (300791) total market value.
Sirio Pharma (300791) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Sirio Pharma's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Sirio Pharma Income Statement — Revenue, Profit & Earnings by Year
Sirio Pharma's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CN¥4.21 Billion | CN¥3.58 Billion | CN¥2.51 Billion | CN¥2.37 Billion | CN¥2.07 Billion |
| Cost of Revenue | CN¥2.89 Billion | CN¥2.50 Billion | CN¥1.73 Billion | CN¥1.59 Billion | CN¥1.39 Billion |
| Gross Profit | CN¥1.32 Billion | CN¥1.08 Billion | CN¥781.71 Million | CN¥775.21 Million | CN¥673.81 Million |
| Research & Development | CN¥125.94 Million | CN¥110.49 Million | CN¥80.72 Million | CN¥83.19 Million | CN¥64.71 Million |
| SG&A | CN¥309.11 Million | CN¥236.20 Million | CN¥273.65 Million | CN¥223.23 Million | CN¥187.60 Million |
| Total Operating Expenses | CN¥3.77 Billion | CN¥3.19 Billion | CN¥2.25 Billion | CN¥2.07 Billion | CN¥1.76 Billion |
| Operating Income | CN¥439.07 Million | CN¥394.53 Million | CN¥259.30 Million | CN¥294.89 Million | CN¥304.81 Million |
| EBITDA | — | — | CN¥426.03 Million | CN¥398.89 Million | CN¥393.48 Million |
| EBIT | — | — | CN¥242.59 Million | CN¥281.11 Million | CN¥273.85 Million |
| Interest Expense | CN¥78.74 Million | CN¥61.86 Million | CN¥42.77 Million | CN¥13.93 Million | CN¥1.80 Million |
| Income Before Tax | CN¥316.65 Million | CN¥273.26 Million | CN¥251.52 Million | CN¥280.90 Million | CN¥311.96 Million |
| Income Tax Expense | — | — | CN¥39.23 Million | CN¥49.07 Million | CN¥54.60 Million |
| Net Income | CN¥325.06 Million | CN¥281.04 Million | CN¥212.29 Million | CN¥231.83 Million | CN¥257.37 Million |
Sirio Pharma Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Sirio Pharma's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CN¥5.49 Billion | CN¥5.20 Billion | CN¥4.19 Billion | CN¥3.82 Billion | CN¥2.65 Billion |
| Total Current Assets | CN¥2.02 Billion | CN¥1.93 Billion | CN¥2.43 Billion | CN¥1.91 Billion | CN¥1.32 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥115.20 Million | CN¥200.66 Million | CN¥79.13 Million | CN¥530.77 Million | CN¥473.49 Million |
| Net Receivables | CN¥675.01 Million | CN¥612.75 Million | CN¥459.80 Million | CN¥341.76 Million | CN¥261.42 Million |
| Inventory | CN¥481.66 Million | CN¥481.06 Million | CN¥232.58 Million | CN¥239.61 Million | CN¥266.77 Million |
| Property, Plant & Equipment | — | — | CN¥1.33 Billion | CN¥1.17 Billion | CN¥768.05 Million |
| Goodwill | CN¥417.10 Million | CN¥420.73 Million | CN¥163.05 Million | CN¥158.59 Million | CN¥176.28 Million |
| Total Liabilities | CN¥2.84 Billion | CN¥2.63 Billion | CN¥1.48 Billion | CN¥1.28 Billion | CN¥466.95 Million |
| Total Current Liabilities | CN¥824.54 Million | CN¥751.13 Million | CN¥469.69 Million | CN¥332.44 Million | CN¥387.06 Million |
| Long-term Debt | CN¥1.16 Billion | CN¥1.05 Billion | CN¥908.36 Million | CN¥852.28 Million | — |
| Net Debt | CN¥574.40 Million | CN¥514.56 Million | — | CN¥136.85 Million | — |
| Total Stockholder Equity | CN¥2.51 Billion | CN¥2.39 Billion | CN¥2.70 Billion | CN¥2.54 Billion | CN¥2.18 Billion |
| Retained Earnings | CN¥1.52 Billion | CN¥1.41 Billion | CN¥1.28 Billion | CN¥1.14 Billion | CN¥978.14 Million |
Sirio Pharma Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Sirio Pharma generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥566.97 Million | CN¥386.08 Million | CN¥444.86 Million | CN¥341.38 Million | CN¥319.57 Million |
| Capital Expenditures | CN¥412.13 Million | CN¥451.70 Million | CN¥293.69 Million | CN¥524.68 Million | CN¥223.14 Million |
| Free Cash Flow | CN¥154.84 Million | CN¥-65.62 Million | CN¥151.17 Million | CN¥-183.31 Million | CN¥96.43 Million |
| Investing Cash Flow | — | — | CN¥283.91 Million | CN¥-735.48 Million | CN¥-394.98 Million |
| Financing Cash Flow | — | — | CN¥-77.90 Million | CN¥906.11 Million | CN¥-92.91 Million |
| Dividends Paid | CN¥219.63 Million | CN¥83.83 Million | CN¥76.09 Million | CN¥72.53 Million | CN¥25.86 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥239.27 Million | CN¥256.96 Million | CN¥126.72 Million | CN¥104.06 Million | CN¥79.72 Million |
| Change in Cash | CN¥110.64 Million | CN¥-867.52 Million | CN¥680.72 Million | CN¥500.74 Million | CN¥-180.48 Million |
Sirio Pharma Earnings History — EPS Actual vs. Analyst Estimates
Track Sirio Pharma's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 29, 2025 | 0.32 | — | — |
| Aug 26, 2025 | 0.30 | — | — |
| Apr 23, 2025 | 0.36 | — | — |
| Oct 23, 2024 | 0.37 | — | — |
| Aug 11, 2024 | 0.51 | — | — |
| Apr 21, 2024 | 0.53 | — | — |
| Oct 25, 2023 | 0.47 | — | — |
| Aug 24, 2023 | 0.40 | — | — |